627 results on '"Seror, Raphaèle"'
Search Results
2. 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
3. Actualisation 2024 des recommandations de la Société française de rhumatologie pour le diagnostic et la prise en charge des personnes souffrant de polyarthrite rhumatoïde
4. Recommandations de la Société française de rhumatologie pour la prise en charge en pratique courante des patients atteints de pseudopolyarthrite rhizomélique
5. Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study
6. Comorbidités et facteurs pronostiques de la maladie de Sjögren
7. Recommandations françaises 2023 pour le diagnostic et la prise en charge des bursites septiques prépatellaires et olécraniennes
8. Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica
9. High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fracture
10. [18F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects
11. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
12. The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
13. Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group
14. 2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis
15. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study
16. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
17. Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study
18. Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort
19. Cancer screening in chronic inflammatory rheumatic diseases
20. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study
21. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
22. Associations between ocular and extra-ocular assessment in primary Sjögren's syndrome*
23. Lifetime female hormonal exposure and risk of rheumatoid arthritis in postmenopausal women: Results from the French E3N cohort
24. Dépistage d’un cancer au cours d’un rhumatisme inflammatoire chronique
25. Comment suivre un patient atteint du syndrome de Sjögren ?
26. Traitements futurs de la maladie de Sjögren
27. Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice
28. Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases
29. Recommandations de la Société française de rhumatologie sur l’alimentation des patients ayant un rhumatisme inflammatoire chronique
30. Thérapies ciblant l’inflammation et risque de cancer
31. Épidémiologie de l’atteinte dermatologique dans le syndrome de Sjögren : données provenant de trois populations françaises de Syndrome de Sjogren primitif (TEARS, ASSESS, diapSS)
32. Recommandations de la Société Française de Rhumatologie pour la prise en charge en pratique courante des patients atteints de Pseudo Polyarthrite Rhizomélique
33. Inflammation-targeted therapies and cancer
34. Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)
35. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
36. Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
37. Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
38. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
39. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.
40. Current and future therapies for primary Sjögren syndrome
41. Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome
42. Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry.
43. 2020 French recommendations on the management of septic arthritis in an adult native joint
44. Recommandations françaises 2020 sur la prise en charge des arthrites septiques sur articulation native de l’adulte
45. Effect of Lymphoma Treatment Approaches on Hematologic Response and Autoimmune Disease Activity in Sjögren's Patients with Lymphoma
46. Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
47. Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials
48. Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR)
49. Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et al
50. Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.